Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Identify Which Dividend Aristocrats ETF Has Highest Expense Ratio and discuss implications for costs and performance.
27,586 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A failing satellite firm pivoted by selling spectrum to SpaceX, triggering a sharp stock surge and turning investor b...
Markets react as Trump signals an interim Iran deal to reopen the Strait of Hormuz. The move could ease shipping disr...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
Tilray’s stock has fallen dramatically this year. This in-depth guide breaks down what’s driving the drop, whether th...
Chevron is expanding its footprint beyond traditional oil and gas as it eyes large-scale power deals. A landmark 2.7 ...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...
Campbell’s posts worst quarters as revenue and margins deteriorate across key segments. The company trims full-year t...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
NVIDIA's Jensen Huang publicly praised Marvell at a major tech event, triggering a sharp stock move and fresh trillio...
GM and Ford are expanding into battery storage, boosting competition for Tesla and signaling a broader shift in how a...